经皮心肌内室间隔射频消融治疗HOCM的5年随访结果
该研究评估了经皮心肌内室间隔射频消融(PIMSRA)治疗肥厚型梗阻性心肌病(HOCM)的5年随访结果。27例严重症状性HOCM患者接受PIMSRA,长期随访显示纽约心功能分级、加拿大心血管学会分级及运动诱发的晕厥发作均显著改善,左心室流出道压差持续降低,室间隔厚度、左室后壁厚度及左房内径减小,心脏磁共振显示左室质量指数和左房容积指数下降、左室舒张末期容积指数和每搏输出量指数增加,左室整体纵向应变改善。结论认为PIMSRA可有效缓解HOCM患者症状并长期改善血流动力学。
要点
- PIMSRA可显著改善HOCM患者心功能分级和运动诱发晕厥。
- 术后5年左室流出道压差(静息和运动后)持续降低。
- 长期随访未观察到恶性室性心律失常和心力衰竭事件。
核心结论
- PIMSRA能有效缓解HOCM患者症状并长期改善血流动力学。
主要发现
- 26例患者纽约心功能分级、加拿大心血管学会分级及运动诱发的晕厥发作显著改善(均p<0.01)。
- 左室流出道压差持续降低:静息从95.0降至9.0 mmHg(p<0.001),运动后从130.5降至21.0 mmHg(p<0.001)。
- 超声显示室间隔厚度、左室后壁厚度及左房内径减小(均p<0.001)。
- 心脏磁共振显示左室质量指数和左房容积指数下降、左室舒张末期容积指数和每搏输出量指数增加(均p<0.05)。
- 左室整体纵向应变从术前-11.9%±3.7%改善至末次检查-13.1%±3.9%(p<0.001),未观察到恶性室性心律失常和心力衰竭事件。
临床怎么用
- 对于严重症状性HOCM患者,PIMSRA可作为长期改善症状和血流动力学的一种治疗选择。
局限性
- 研究样本量较小(27例),且为单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective is to evaluate the 5-year follow-up results of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) for hypertrophic obstructive cardiomyopathy (HOCM), including clinical status, electrocardiographic and echocardiographic characteristics. METHODS: 27 patients (age: 44.3±15.5 years; 67% men, 33% women) with severely symptomatic HOCM who underwent PIMSRA from October 2016 to September 2017 were included. Their clinical status, resting and exercise stress echocardiography, electrocardiography and cardiac MRI (CMRI) after long-term follow-up were assessed. RESULTS: One patient died of intracerebral haemorrhage 1 year post procedurally. The New York Heart Association class, Canadian Cardiovascular Society class and exercise-induced syncopal attacks improved significantly in 26 patients (all p<0.01). Left ventricular (LV) outflow tract gradients revealed sustained reduction (resting: from 95.0 to 9.0 mm Hg, p<0.001; post exercise: from 130.5 to 21.0 mm Hg, p<0.001). The echocardiographic evaluation revealed decreased septal thickness, LV posterior wall thickness and left atrial (LA) diameter (all p<0.001). CMRI data revealed decrease in LV mass index and LA volume index and increase in LV end-diastolic volume index and stroke volume index between baseline and long-term follow-up (all p<0.05). The global longitudinal strain of LV improved from (-11.9%±3.7%) before the procedure to (-13.1%±3.9%) at the last check (p<0.001). Malignant ventricular arrhythmia and heart failure events were not observed. CONCLUSIONS: PIMSRA can effectively alleviate symptoms in patients with HOCM and improve their hemodynamics in the long term. TRIAL REGISTRATION NUMBER: NCT02888132.
引用
- Ta S, Li J, Hsi DH, et al. Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up. Heart. 2024. PMID: 38388470. doi:10.1136/heartjnl-2023-323606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。